Extended Data Fig. 3: Effect of LPS-5 Phage Therapy on LPS content. | Nature Medicine

Extended Data Fig. 3: Effect of LPS-5 Phage Therapy on LPS content.

From: Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis

Extended Data Fig. 3

Quantification of extracted LPS (ng/CFU) from PsA sputum isolates taken pre- and post-therapy from (A) patient 1 (Npre =1, Npost =3, p=NA), (B) patient 2 (Npre =4, Npost =5, p=0.2857), (C) patient 3 (Npre =1, Npost =1, p=NA), (D) patient 4 (Npre =1, Npost =5, p=NA), (E) patient 5 (Npre =2, Npost =4, p=0.5333), (F) patient 6 (Npre =3, Npost =3, p=0.0403), (G) patient 7 (Npre =2, Npost =5, p=0.0952), (H) patient 8 (Npre =3, Npost =1, p=NA), and (I) patient 9 (Npre =1, Npost =3, p=NA). Data representative of two independent experiments; error bars represent median (Welch’s t test or Mann-Whitney test).

Back to article page